Inmed Pharmaceuticals Inc.
13F holders, Q2 2024 (June 30)14holders −4
4new positions
8sold out
1famous investor
$0.26avg. 13F price*
At the end of Q2 2024, 14 institutions reported holding Inmed Pharmaceuticals Inc. in their 13F filings, down 4 from Q1 2024. 4 opened new positions and 8 sold out. The largest holders were Sabby Management, LLC ($82K), Virtu Financial LLC ($23K) and XTX Topco Ltd ($5K). One famous investor held it Ken Griffin (0.0% of Citadel Advisors's portfolio).
- Company
- Inmed Pharmaceuticals Inc.
- CUSIP
- 457637601
- Latest filing quarter
- Q3 2024
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 4 | $32K |
| Exits | 8 | $113K |
All 13F filers, Q1 2024 → Q2 2024: 120,584 shares bought and 366,172 shares sold, net −245,588 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 14 holders
| Sabby Management, LLC | 1.21% | Reduce -15.1% | 307,236 | $82K |
| Virtu Financial LLC | 0.00% | New | 86,684 | $23K |
| XTX Topco Ltd | 0.00% | New | 17,819 | $5K |
| HRT Financial LP | 0.00% | New | 15,996 | $4K |
| Citadel Advisors | 0.00% | Reduce -4.9% | 12,097 | $3K |
| Qube Research & Technologies Ltd | 0.00% | No change | 200 | $54 |
| Bank of America Corp. | 0.00% | No change | 100 | $26 |
| TD Waterhouse Canada Inc. | 0.00% | New | 85 | $21 |
| Osaic Holdings, Inc. | 0.00% | Reduce -21.9% | 32 | $7 |
| AllSquare Wealth Management LLC | 0.00% | No change | 21 | $6 |
| Global Retirement Partners, LLC | 0.00% | No change | 6 | $2 |
| Toronto Dominion Bank | 0.00% | No change | 2 | $1 |
| Royal Bank of Canada | 0.00% | No change | 25 | $0 |
| Gables Capital Management Inc. | 0.00% | No change | 1 | $0 |
"% of holder's portfolio" is INMED PHARMACEUTICALS INC's weight in each manager's 13F, not the share of Inmed Pharmaceuticals Inc. the manager owns.